Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.22.2.2
Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net income (loss) available to stockholders $ (256,712) $ 1,466,697 $ (1,023,521) $ 3,633,035
Weighted average shares outstanding - basic 24,850,261 24,850,261 24,850,261 24,850,261
Effect of dilutive securities:        
Weighted average shares outstanding - Diluted 24,850,261 25,154,905 24,850,261 25,131,165
Net income (loss) per share - basic (in USD per share) $ (0.01) $ 0.06 $ (0.04) $ 0.15
Net income (loss) per share - diluted (in usd per share) $ (0.01) $ 0.06 $ (0.04) $ 0.14
Stock Options        
Effect of dilutive securities:        
Stock options 0 304,644 0 280,904
Anti-dilutive shares underlying stock options outstanding 971,001 777,296 836,001 777,296